MOXIFLOXACIN

FLOXSAFE IV

400mg/250ml Solution for IV Infusion Antibacterial Lock the safety!

• No left over self-collapsing bag
• Extra-Medication Port - Prevents drug contamination
• Non-PVC Flexible Bag - Prevents drug interaction
• Easy Handling - Compared to other IV Fluroquinolones preperation available in the market

INDICATIONS DAILY DOSE ROUTE OF ADMINISTRATION USUAL DURATION Community Acquired Pnemonia (CAP) - 400mg IV 7-14 DAYS Hospital Acruired Pnenomia (HAP) - 400mg IV/PO 7-14 DAYS Ventilator Acquired Pneun MOXIFLOXACIN FLOXSAFE 400 mg Film-Coated Tablet Antibacterial (Flouroquinoles)

• Easy switch from I.V. to Oral
• Approved for treating severe and life treatening infections.
• Bioequivalent to the innovator.

DON'T COMPROMISE YOUR SAFETY Moxifloxacin [FloxSafe] is indicated in combination with other antituberculosis agents for the treatment of tuberculosis caused by Mycobacterium tuberculosis Moxifloxacin [FloxSafe] is the indicated as a secondline antinycobacterial drug when use of first line drugs is not appropriate due to resistance or intolerance WHO treatment guidelines for drug resistant tuberculosiss 2016 [update] Therapautic Indications:

• AECOPD
• Acute Bacterial Sinusities
• Community Aquired Pneumonia

Download patient information leaflet Click here